Business
Invitrogen Corp., which makes technologies for disease research and drug discovery, agreed Thursday to pay $6.4 billion in cash and stock for scientific instruments maker Applera Corp.’
June 13, 2008
Invitrogen Corp., a maker of chemical kits used to analyze and clone genes, agreed to buy BioReliance Corp. for $430 million to expand its production capabilities for biotechnology customers.
Dec. 25, 2003
Technology and the Internet
Incyte Genomics Inc., which is being sued by rival Invitrogen Corp. over patents for gene cloning, has filed its own patent-infringement suit against Invitrogen.
Nov. 28, 2001
Invitrogen Corp., a developer of medical kits for genetic research, has agreed to buy chemical maker Dexter Corp. and biological-products maker Life Technologies Inc. for $1.9 billion in cash and stock to build gene-research services.
July 10, 2000
* JetBlue Airways Corp. said it will add flights from Long Beach Airport to New York’s John F.
Feb. 5, 2003
Health-care stocks will become more of a force in the Nasdaq 100 when the benchmark index--often considered a proxy for the technology sector--is shuffled next week.
Dec. 18, 2001
Trading: After Friday’s disruption, officials revise the numbers, affecting quarterly returns on portfolios.
July 3, 2001
When state legislators walk into a statewide biotechnology industry meeting today in La Jolla, they’ll be greeted by piles of brochures that other states are using to lure biotech firms out of California.
Sept. 11, 1992
The market for initial public offerings looks strong so far this year, especially for several upcoming deals by California-based companies, market specialists say.
Jan. 18, 1999
Michael D.
April 20, 2005